RB1 and neoplasm: In RB, where cell-cycle regulation intersects at the RB/E2F node, attenuation of the AKT/mTOR pathway by circ-0001649 is proposed to diminish cyclin-CDK activity, thereby reinforcing G1-phase arrest and sensitizing tumor cells to cytotoxic stress (58).